Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622936 | SCV000742668 | pathogenic | Inborn genetic diseases | 2017-06-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000627204 | SCV000748191 | pathogenic | not provided | 2018-01-26 | criteria provided, single submitter | clinical testing | The R653X variant has been published as a homozygous pathogenic variant in a patient diagnosed with autosomal recessive retinitis pigmentosa (Perez-Carro et al., 2016). The R653X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The R653X nonsense variant in the PDE6A gene is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is interpreted to be pathogenic. |
Mendelics | RCV000504732 | SCV001136999 | pathogenic | Retinitis pigmentosa | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000627204 | SCV001249585 | pathogenic | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000627204 | SCV001403249 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg653*) in the PDE6A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PDE6A are known to be pathogenic (PMID: 7493036, 22128245, 23847139). This variant is present in population databases (rs753942596, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 26806561, 29693493, 30619975). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 437983). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV000627204 | SCV001446816 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Ophthalmic Genetics Group, |
RCV000504732 | SCV004030432 | pathogenic | Retinitis pigmentosa | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |
NIHR Bioresource Rare Diseases, |
RCV000504732 | SCV000598726 | likely pathogenic | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research | |
Sharon lab, |
RCV000504732 | SCV001161178 | pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |